跳至主要内容
临床试验/NCT00190034
NCT00190034暂停4 期

N-Acetylcysteine Protects Against Acute Renal Insult in Patients With Abnormal Renal Function Undergoing Cardiopulmonary Bypass.

Far Eastern Memorial Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2005年1月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
暂停
入组人数
60
试验地点
1
主要终点
Serum creatinine and blood urea nitrogen: before, 48 h and 5 days after the operation procedure.

研究概览

简要总结

The purpose of this study is to determine whether N-acetylcysteine is effective in the prophylaxis of post-cardiopulmonary bypass acute renal impairment.

详细描述

BACKGROUND Reactive oxygen species have been shown to cause contrast-induced nephrotoxicity (CIN). According to previous studies, the N-acetylcysteine has been proved to be advantageous in the avoidance of CIN. We seek to evaluate the efficacy of the antioxidant N-acetylcysteine in limiting the nephrotoxicity after cardiovascular surgery with cardiopulmonary bypass.

METHODS We will prospectively study 60 patients who will receive a cardiovascular surgery with cardiopulmonary bypass. Patients will be randomly assigned to receive either N-acetylcysteine (600 mg orally twice daily for 4 doses) with 0.45% saline intravenously, before and after cardiopulmonary bypass, or placebo with 0.45% saline. Serum creatinine and blood urea nitrogen will be measured before, 48 h and 5 days after the operation procedure.

Expected results Prophylactic oral administration of the antioxidant N-acetylcysteine, along with hydration, will significantly reduce the acute renal damage induced by CPB in patients with chronic renal insufficiency that need cardiovascular procedures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •All patients who will received cardiac surgery with cardiopulmonary bypass

排除标准

  • •Dialyzed patients
  • •Acute renal failure
  • •Advanced left ventricular systolic dysfunction defined as left ventricular ejection fraction ≦ 35%.
  • •Acute chronic obstructive lung disease or asthma exacerbation
  • •Allergy to N-acetylcysteine

结局指标

主要结局

Serum creatinine and blood urea nitrogen: before, 48 h and 5 days after the operation procedure.

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验